- Long-term management of oral cladribine treatment in multiple sclerosis2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Electroconvulsive therapy: does a history of pharmacoresistance influence the therapeutic response ?2001 | Second Faculty of Medicine
- Long-term therapeutic response after encorafenib and binimetinib therapy - case report2023 | First Faculty of Medicine
- Interindividual differences in terapeutic effect - now is the time to solve the problem2010 | Third Faculty of Medicine
- Gastrointestinal stromal tumor molecular diagnostics in relation to the prediction of a therapeutic response to targeted biological therapy2011 | Second Faculty of Medicine
- Oral cladribine in the treatment of multiple sclerosis - data from the national registry ReMuS(R) registry2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Treatment response to bortezomib in multiple myeloma correlates with plasma hepatocyte growth factor concentration and bone marrow thrombospondin concentration2010 | First Faculty of Medicine
- Prediction of therapeutic response in patients suffering from obsessive compulsive disorder resistant to the treatment with psychopharmacs2008 | Publication without faculty affiliation
- Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: An open randomized clinical trial (EUFEST)2009 | Faculty of Medicine in Hradec Králové
- Gender difference in disease severity and treatment outcomes among patients with rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) treated for one year with certolizumab pegol - analysis from the nationwide ATTRA registry of biological therapy2021 | First Faculty of Medicine
- Gender difference in disease severity and treatment outcomes among patients with rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) starting treatment with targeted therapies in the Czech Republic - analysis from the nation-wide ATTRA registry of biological therapy2021 | First Faculty of Medicine
- Association between genes polymorphisms, and infliximab dependent patientsPublication without faculty affiliation
- Umění léčby a posun k farmakoterapeutické prevenci revmatoidní artritidy2022 | First Faculty of Medicine
- Bronchial asthma and obesity2013 | Faculty of Medicine in Hradec Králové
- Pharmacotherapy of Pain2009 | Third Faculty of Medicine
- 677TT Genotype Is Associated with Elevated Risk of Methotrexate (MTX) Toxicity in Juvenile Idiopathic Arthritis: Treatment Outcome, Erythrocyte Concentrations of MTX and Folates, and MTHFR Polymorphisms2010 | First Faculty of Medicine
- The role of imumunie system in pathophysiology of schizophrenia2009 | Publication without faculty affiliation
- Rešerše zajímavých článků ze zahraniční literatury2020 | First Faculty of Medicine
- High-dose Interferon Alpha in Treatment of Patients with Malignant Melanoma, Monitoring of Predictive and Prognostic Biomarkers2011 | Faculty of Medicine in Hradec Králové
- Nové možnosti snížení rizika hemolýzy u imunoglobulinových přípravků2018 | Second Faculty of Medicine, Third Faculty of Medicine
- Eosinophilia and predicting response to inhaled corticosteroids in chronic obstructive pulmonary disease2017 | Publication without faculty affiliation
- Complete therapeutic response to anti-PD1 therapy in patient with advanced melanoma and resistance to targeted therapy of BRAF inhibitors2018 | First Faculty of Medicine
- Intravenous beta-blockers in acute medicine2021 | Publication without faculty affiliation
- Ustekinumab in treating psoriatic arthritis +12015 | First Faculty of Medicine
- Mechanisms of resistance to melanoma immunotherapy2023 | First Faculty of Medicine
- Antipsychotic Drug Treatment in First-Episode Psychosis. Should Patients be Switched to a Different Antipsychotic Drug After 2, 4, or 6 Weeks of Nonresponse?2010 | Faculty of Medicine in Hradec Králové
- Treating inflammatory bowel diseases in the 21st century: individualized therapy and telemedicine2021 | First Faculty of Medicine
- Effect of target therapy with BRAF and MEK inhibitors on the immune system in metastatic melanoma2023 | First Faculty of Medicine
- Experience of hormonal therapy for patients with multiple sclerosis2007 | First Faculty of Medicine